Astrazeneca’s AZD-1163 inhibits autoantigen production in rheumatoid arthritis
June 26, 2024
The generation of anti-citrullinated protein autoantibodies (ACPA) are known key drivers in the pathogenesis of rheumatoid arthritis (RA) and are generated by peptidyl arginine deiminases (PADs).